Proto Labs’s (NYSE:PRLB) Q4 Sales Beat Estimates But Stock Drops
Manufacturing services provider Proto Labs (NYSE:PRLB) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 2.6% year on year to $121.8 million. On the other hand, next quarter’s revenue guidance of $124 million was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 18.8% above analysts’ consensus estimates.